Pharmacists See Challenges, Opportunities In Behind-The-Counter Class
This article was originally published in The Tan Sheet
Executive Summary
Pharmacy trade groups welcome the possibility of a behind-the-counter class of drugs, but a pharmacy professor and former FDA Nonprescription Drugs Advisory Committee chairman cautions a third class could create more demand than pharmacists are able to manage